Doctors Accuse NextSource Biotech for Hiking the Price on Key Cancer Drug Nine Times
The cost of a vital cancer drug has gone up 15-fold in four years after its new owner hiked prices on nine separate occasions.
Source: BioSpace
The cost of a vital cancer drug has gone up 15-fold in four years after its new owner hiked prices on nine separate occasions.
Source: BioSpace